Advancing Pharmacoequity in Atrial Fibrillation-The Case for Direct Oral Anticoagulants

By sjmartinez • May 7, 2024

Boursiquot BC, Jackson LR 2nd, Essien UR. Advancing Pharmacoequity in Atrial Fibrillation-The Case for Direct Oral Anticoagulants. JAMA Netw Open. 2024 May 1;7(5):e249403. doi: 10.1001/jamanetworkopen.2024.9403. PMID: 38709538.

Tags: General Internal Medicine, Publications, Veterans Administration

Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older

Chin AT, Ochs HD, Kobayashi R, Abolhassani H, Alachkar H, Barmettler S, Baxendale H, Boiling K, Cantanzaro J, Chua I, Coulter T, Cunningham-Rundles C, Elcombe[...]

Impact of lifting school mask mandates on community SARS-CoV-2 cases, hospitalizations, and deaths: a retrospective observational study

Ertem Z, Danesharasteh A, Anand ST, Jackson NJ, Nelson RE, Schechter-Perkins EM, Fisher L, Doron S, Branch-Elliman W. Impact of lifting school mask mandates on[...]

A Novel Method of Chest Wall Reconstruction Succeeding Pediatric Heart Transplantation Donor-recipient Size Mismatch: 25-year Follow-up

Lesavoy M, March J, Roy I, Laks H, Parmar N. A Novel Method of Chest Wall Reconstruction Succeeding Pediatric Heart Transplantation Donor-recipient Size Mismatch: 25-year[...]